Macular disease - AMD
Dr Elvis Ojaimi first to implant telescopic lens at Epworth Freemasons, Melbourne
An 81-year-old woman with poor vision due advanced macular degeneration has become the first Australian patient to be fitted with...
Read moreDetails
Iveric Bio reveals vision loss reduction data in investigational geographic atrophy therapy
US biopharmaceutical company Iveric Bio has released new data for its avacincaptad pegol (ACP) therapy for geographic atrophy (GA), which...
Read moreDetails
Aflibercept 8mg could become AMD standard-of-care after pivotal trial
The drug company that produces Eylea (2 mg aflibercept) has announced clinical trial results showing the anti-VEGF therapy can be...
Read moreDetails